Insulin-like growth factor 1 and life-history evolution of passerine birds

被引:19
作者
Lodjak, Jaanis [1 ]
Mand, Raivo [1 ]
Magi, Marko [1 ]
机构
[1] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia
关键词
adaptation; comparative study; hormones; insulin-like growth factor 1; phylogeny; trade-off; FACTOR-I; IGF-I; SIGNALING PATHWAYS; OXIDATIVE STRESS; BODY-MASS; EGG SIZE; HORMONE; LONGEVITY; SPAN; RECEPTORS;
D O I
10.1111/1365-2435.12993
中图分类号
Q14 [生态学(生物生态学)];
学科分类号
071012 ; 0713 ;
摘要
1. Natural selection has generated a diversity of ways in which vertebrates allocate their resources between fundamental life-history traits. The availability of possible evolutionary trajectories of these traits is limited by various genetic, physiological and phylogenetic constraints. This causes trade-offs due to shared resource pools for, or genetic linkage of, competing traits. The majority of these trade-offs are mediated by hormones and create the variability in phenotypes that can be -observed in nature. 2. Insulin-like growth factor 1 (IGF-1) is an evolutionarily conserved peptide, which has been shown to be essential in the regulation of body size, the pattern of reproductive investment and life span across a broad taxonomic range of model species in laboratory and domesticated conditions. However, studies addressing corresponding evolutionary hypotheses on a broader scale and in free-living vertebrates are very rare. 3. In this phylogenetic comparative study on free-living passerines (Passeriformes), we explore the way in which plasma IGF-1 levels underlie the evolution of body size and demographic fitness correlates (clutch size, egg weight, life span). 4. We showed firstly that IGF-1 levels were positively associated with the body size of passerines, although smaller birds had larger IGF-1-mediated investment into building up their body faster. IGF-1 levels were negatively associated with life span of passerines, and more so in birds with smaller body weight. Finally, IGF-1 levels were negatively associated with clutch size in heavier species, and positively associated with egg weight in species with higher body weight and longer duration of parental care. The pattern was opposite in species with smaller body weight and shorter duration of parental care. 5. The described evolutionary framework indicates that variation in IGF-1 levels can be regarded as an important mechanism that may underlie life-history evolution in passerines. IGF-1 could act as a physiological link mediating the inter-regulatory growth-reproduction-lifespan "life-history triangle" on the pace-of-life continuum. Interestingly, body weight and investment into parental care have likely imposed a constraining effect on the IGF-1-mediated co-evolution of demographic fitness traits, such as life span or reproductive investment. This has limited the availability of adaptive pathways via which those traits could evolve as passerines diversified.
引用
收藏
页码:313 / 323
页数:11
相关论文
共 50 条
  • [41] Insulin-like growth factor-1 and insulin-like growth factor binding protein 3 and risk of postoperative cognitive dysfunction
    Jiang, Jue
    Chen, Zhifeng
    Liang, Bing
    Yan, Jia
    Zhang, Ying
    Jiang, Hong
    SPRINGERPLUS, 2015, 4 : 1 - 7
  • [42] The Role of Insulin-Like Growth Factor 1 in Delirium: A Systematic Review and Meta-Analysis
    Adamis, Dimitrios
    Eikelenboom, Piet
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2023, 51 (06) : 449 - 459
  • [43] Risk of prevalent and incident dementia associated with insulin-like growth factor and insulin-like growth factor-binding protein 3
    Almeida, O. P.
    Hankey, G. J.
    Yeap, B. B.
    Chubb, S. A. Paul
    Gollege, J.
    Flicker, L.
    MOLECULAR PSYCHIATRY, 2018, 23 (08) : 1825 - 1829
  • [44] The use of insulin-like growth factor 1 improved the parameters of the seminogram in a patient with severe oligoasthenoteratozoospermia
    Mora Rodriguez, Jose Arturo
    Porchia, Leonardo M.
    Camargo, Felipe
    Lopez-Bayghen, Esther
    SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
  • [45] Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia
    Arinami, Hiroshi
    Watanabe, Yuichiro
    Suzuki, Yutaro
    Tajiri, Misuzu
    Tsuneyama, Nobuto
    Someya, Toshiyuki
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [46] Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 -Biomarkers for Skeletal Maturity Assessment in Class II Malocclusion
    Yezdani, Arif
    Padmavathy, Kesavaram
    Kumar, Kishore
    PESQUISA BRASILEIRA EM ODONTOPEDIATRIA E CLINICA INTEGRADA, 2024, 24
  • [47] Insulin, insulin-like growth factor 1 and insulin-like growth factor binding protein 3 serum concentrations in patients with adenomatous colon polyps
    Janiak, Adam
    Oset, Piotr
    Talar-Wojnarowska, Renata
    Kumor, Anna
    Malecka-Panas, Ewa
    PRZEGLAD GASTROENTEROLOGICZNY, 2013, 8 (05): : 308 - 314
  • [48] Changes in the expression of insulin-like growth factor 1 variants in the postnatal brain development and in neonatal hypoxia-ischaemia
    Beresewicz, Malgorzata
    Majewska, Monika
    Makarewicz, Dorota
    Vayro, Steven
    Zablocka, Barbara
    Gorecki, Dariusz C.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2010, 28 (01) : 91 - 97
  • [49] Diverse Roles of Growth Hormone and Insulin-Like Growth Factor-1 in Mammalian Aging: Progress and Controversies
    Sonntag, William E.
    Csiszar, Anna
    deCabo, Raphael
    Ferrucci, Luigi
    Ungvari, Zoltan
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2012, 67 (06): : 587 - 598
  • [50] Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age
    Duran-Ortiz, Silvana
    List, Edward O.
    Basu, Reetobrata
    Kopchick, John J.
    PITUITARY, 2021, 24 (03) : 438 - 456